{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:01:51Z","timestamp":1783983711967,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.clbc.2019.05.004","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T21:03:27Z","timestamp":1558127007000},"page":"354-362.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis"],"prefix":"10.1016","volume":"19","author":[{"given":"Yunyun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina D.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Bassam","family":"Sonbol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nita","family":"Maihle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Ching","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2019.05.004_bib1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2019.05.004_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrclinonc.2011.199","article-title":"The role of aspirin in cancer prevention","volume":"9","author":"Thun","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clbc.2019.05.004_bib3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2019.05.004_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00001648-199403000-00003","article-title":"Aspirin use and lung, colon, and breast cancer incidence in a prospective study","volume":"5","author":"Schreinemachers","year":"1994","journal-title":"Epidemiology"},{"key":"10.1016\/j.clbc.2019.05.004_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-017-0605-6","article-title":"Role of aspirin in breast cancer survival","volume":"19","author":"Chen","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.clbc.2019.05.004_bib6","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1200\/JCO.2009.22.7918","article-title":"Aspirin intake and survival after breast cancer","volume":"28","author":"Holmes","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.05.004_bib7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/bjc.2014.264","article-title":"Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study","volume":"111","author":"Fraser","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2019.05.004_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10549-011-1747-0","article-title":"Aspirin use and breast cancer risk: a meta-analysis","volume":"131","author":"Luo","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2019.05.004_bib9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12609-013-0115-y","article-title":"Aspirin and breast cancer prevention","volume":"5","author":"Lazzeroni","year":"2013","journal-title":"Curr Breast Cancer Rep"},{"key":"10.1016\/j.clbc.2019.05.004_bib10","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1200\/JCO.2013.50.0322","article-title":"Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer","volume":"31","author":"Domingo","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.05.004_bib11","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1056\/NEJMoa1207756","article-title":"Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival","volume":"367","author":"Liao","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2019.05.004_bib12","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1158\/0008-5472.CAN-16-2400","article-title":"Aspirin suppresses growth in PI3Kmutant breast cancer by activating AMPK and inhibiting mTORC1 signaling","volume":"77","author":"Henry","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2019.05.004_bib13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1054\/bjoc.2000.1709","article-title":"Breast cancer and NSAID use: a meta-analysis","volume":"84","author":"Khuder","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2019.05.004_bib14","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1200\/JCO.1999.17.6.1710","article-title":"Expression of BAG-1 in invasive breast carcinomas","volume":"17","author":"Tang","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.05.004_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.clbc.2019.05.004_bib16","series-title":"Modelling Survival Data in Medical Research","author":"Collett","year":"2015"},{"key":"10.1016\/j.clbc.2019.05.004_bib17","doi-asserted-by":"crossref","first-page":"11479","DOI":"10.1038\/ncomms11479","article-title":"The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes","volume":"7","author":"Pereira","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.clbc.2019.05.004_bib18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.clbc.2019.05.004_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.clbc.2019.05.004_bib20","first-page":"1","article-title":"MatchIt: nonparametric preprocessing for parametric causal inference","volume":"42","author":"Ho","year":"2011","journal-title":"J\u00a0Statistic Software"},{"key":"10.1016\/j.clbc.2019.05.004_bib21","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.bjc.6600760","article-title":"A\u00a0population based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin","volume":"88","author":"Friis","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2019.05.004_bib22","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","article-title":"Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies","volume":"369","author":"Flossmann","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2019.05.004_bib23","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/annonc\/mdw246","article-title":"PIK3CA mutations in HER2-positive breast cancer: an ongoing conundrum","volume":"27","author":"Goel","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2019.05.004_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13058-017-0840-7","article-title":"Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2defined breast cancer: the California Teachers Study","volume":"19","author":"Clarke","year":"2017","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2019.05.004_bib25","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1073\/pnas.0907011107","article-title":"PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor\u2013 positive breast cancer","volume":"107","author":"Loi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clbc.2019.05.004_bib26","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1158\/0008-5472-CAN-04-3913","article-title":"PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma","volume":"65","author":"Saal","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2019.05.004_bib27","doi-asserted-by":"crossref","first-page":"e53292","DOI":"10.1371\/journal.pone.0053292","article-title":"PIK3CA genotype and a PIK3CA mutationrelated gene signature and response to everolimus and letrozole in estrogen receptor positive breast cancer","volume":"8","author":"Loi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2019.05.004_bib28","doi-asserted-by":"crossref","first-page":"6784","DOI":"10.1158\/1078-0432.CCR-12-1785","article-title":"Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer","volume":"18","author":"Chandarlapaty","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2019.05.004_bib29","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/bjc.2013.164","article-title":"Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab","volume":"108","author":"Cizkova","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2019.05.004_bib30","doi-asserted-by":"crossref","first-page":"14372","DOI":"10.1073\/pnas.1303204110","article-title":"Mutant PIK3CA accelerates HER2driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies","volume":"110","author":"Hanker","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clbc.2019.05.004_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.gastro.2007.09.035","article-title":"Aspirin dose and duration of use and risk of colorectal cancer in men","volume":"134","author":"Chan","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clbc.2019.05.004_bib32","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/gutjnl-2014-308260","article-title":"Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis","volume":"64","author":"Li","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.clbc.2019.05.004_bib33","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.clbc.2019.05.004_bib34","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1158\/0008-5472.CAN-12-2432","article-title":"Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T cell-mediated lysis","volume":"73","author":"Akalay","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2019.05.004_bib35","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/bcr3113","article-title":"PIK3CA mutation impact on survival in breast cancer patients and in ER\u03b1, PR and ERBB2-based subgroups","volume":"14","author":"Cizkova","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2019.05.004_bib36","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1158\/1078-0432.CCR-09-0632","article-title":"PIK3CA mutation associates with improved outcome in breast cancer","volume":"15","author":"Kalinsky","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2019.05.004_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10549-005-9048-0","article-title":"PIK3CA mutations in breast cancer are associated with poor outcome","volume":"96","author":"Li","year":"2006","journal-title":"Breast Cancer Res Treat"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820919300667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820919300667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:19:01Z","timestamp":1761513541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820919300667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1526820919300667"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2019.05.004","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2019.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}